INHIXA sol inj 40 mg/0.4ml 2 ser pré 0.4 ml
7680674540045
CH-67454
B01AB05
06.03.3.
1 / 3
google
Details
- Product number
- 6745402
- CPT
- -
- Packaging group
- 2
- Unit
- Fertigspritze(n)
- Composition
- enoxaparinum natricum 40 mg corresp. 4000 U.I. anti-Xa, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.23 mmol.
Articles (1)
Inhixa 4000 IE (40 mg), Injektionslösung
Injektionslösung
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.23 MMOL | Substance | HBESI |
Reimbursement information
Public price
CHF 15.30
Specialties list
Yes
Generic
No
SL addition date:
01/08/2020
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 67454
- Drug name
- Inhixa, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- B01AB05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/06/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 06.03.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INHIXA sol inj 40 mg/0.4ml 2 ser pré 0.4 ml
- Description (DE)
- INHIXA Inj Lös 40 mg/0.4ml 2 Fertspr 0.4 ml
- Market launch
- 10/06/2020
- Narcotic (BTM)
- No